Related Experiment Video
Updated: Mar 3, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
Smad3 mutant mice develop colon cancer with overexpression of COX-2
Yu-Ping Zhu1, Zhuo Liu1, Zhi-Xuan Fu1
1Department of Colorectal Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Abstract:
Colon cancer is the second most common cause of cancer-associated mortality in human populations. The aim of the present study was to identify the role of cyclooxygenase-2 (COX-2) in Smad3 mutant mice, which are known to develop colon cancer. Homozygous Smad3 (-/-) mutant mice were generated from inbred and hybrid Smad3 mouse strains by intercrossing the appropriate heterozygotes. Immunohistochemistry with COX-2 antibody was performed throughout this experiment and the data was validated and cross-checked with reverse transcription-polymerase chain reaction (RT-PCR). Homozygous mutant Smad3 mice were generated and the overexpression pattern of COX-2 was identified by immunohistochemistry and validated with RT-PCR. The results of the present study demonstrated a link between the Smad3 mutant mice, colon cancer and COX-2. In addition, the overexpression pattern of COX-2 in Smad3 mutant mice that develop colon cancer was identified.
Insights
This study investigated cyclooxygenase-2 (COX-2) in Smad3 mutant mice, which develop colon cancer. Results show a link between Smad3 mutation, colon cancer development, and COX-2 overexpression.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Colon cancer is a leading cause of cancer mortality.
- Smad3 mutant mice are a model for colon cancer development.
- Cyclooxygenase-2 (COX-2) is implicated in various cancers.
Purpose of the Study:
- To elucidate the role of COX-2 in Smad3 mutant mice.
- To investigate the correlation between Smad3 mutation, colon cancer, and COX-2 expression.
- To identify the expression patterns of COX-2 in this colon cancer model.
Main Methods:
- Generation of homozygous Smad3 (-/-) mutant mice.
- Immunohistochemistry using COX-2 antibody.
- Validation of results with reverse transcription-polymerase chain reaction (RT-PCR).
Main Results:
- Successfully generated homozygous Smad3 mutant mice.
- Identified an overexpression pattern of COX-2 in these mice.
- Demonstrated a significant link between Smad3 mutation, colon cancer, and COX-2.
Conclusions:
- Smad3 mutation is associated with colon cancer development in mice.
- Overexpression of COX-2 is a key feature in Smad3 mutant mice with colon cancer.
- COX-2 plays a role in the pathogenesis of colon cancer in this genetic model.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

